AzTrials
AzTrials

Chronic PainNCT04332939

Motor System Activation With Transcranial Direct Current Stimulation and Physical Exercise to Reduce Pain in Elderly

A study testing transcranial direct current stimulation and Physical exercise in people with Chronic Pain, run by Université de Sherbrooke at 2 sites in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Physical exercises are known to reduce chronic pain in elderly individuals by activating the motor system. However, it seems that exercises are not effective for everyone. The investigators believe that elderly individuals with altered corticospinal tract will be those in whom the exercise alone are not sufficient to… Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Chronic Pain
What is being tested?
transcranial direct current stimulation and Physical exercise
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
32 participants
Where
2 sitesCanada
Study dates
1 Dec 2020to Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • To have musculoskeletal chronic pain
  • Not to change medication and life habits during the study

Who cannot join

  • People physically active before the study (more then 150 min of moderate to vigorous exercise par week)
  • To have an uncontrolled cardiovascular disease
  • To have orthopedic limitation or contraindication to physical exercise
  • To have contraindication to tDCS
  • To have contraindication to TMS
  • To have contraindication to MRI

Trial locations and contacts

2 sites in 1 country.

Canada2 sites, 2 recruiting
  • Research Centre on Aging

    Sherbrooke, Quebec, J1H 4C4

    Guillaume Léonard, pht, PhD, 1 819-780-2220 ext. 45246, guillaume.leonard2@usherbrooke.ca

    Recruiting
  • Grace Village

    Sherbrooke, Quebec, J1M 0C6

    Guillaume Léonard, pht, PhD

    Recruiting

Other trials in Canada

About this study

Official title: Activating Motor System to Relieve Pain in Elderly: What is the Role of Physical Exercise and Transcranial Stimulation

Physical exercises are known to reduce chronic pain in elderly individuals by activating the motor system. However, it seems that exercises are not effective for everyone. The investigators believe that elderly individuals with altered corticospinal tract will be those in whom the exercise alone are not sufficient to relieve pain. For those patients, adding an exogenous stimulation of the motor system such as transcranial direct current stimulation (tDCS) would facilitate the corticospinal tract, and consequently, would help exercises to relieve chronic pain. The investigators hypothesize that combining tDCS with the exercises will be more effective than exercises alone, but only in individuals who initially show low corticospinal projections.

Read the detailed description

Prevalence and intensity of chronic pain increases substantially with age. According to several studies, physical exercises are effective to reduce chronic pain in elderly. However, it seems that exercises are not effective for everyone. One of the hypotheses raised is that the people in whom the exercises have no effect would be those with an alteration of the corticospinal tract. Transcranial direct current stimulation (tDCS) is a non-invasive neurostimulation technique known to facilitate the corticospinal tract when applied over the motor cortex.

Elderly suffering from chronic pain will be recruited in this double-blind, parallel-group, randomised control trial. Participants will be randomized to receive exercises combined to real tDCS (5 daily sessions, 2 mA, 20 minutes) or to sham tDCS. Intervention will last 8 weeks at a rate of 3 workouts per week.

Conditions
Chronic Pain
Being tested
transcranial direct current stimulation, Physical exercise
Keywords
transcranial direct current stimulation, physical exercise, corticospinal projections
Medical subject headings
Chronic Pain, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • transcranial direct current stimulationOther

    real tDCS sessions

  • Physical exerciseOther

    Aerobic exercise and physical training combined with sham tDCS

Study groups in NCT04332939
Study groupRoleWhat they receive
Exercise + real tDCSExperimentalIntervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week. For the first week, participants will receive 5 daily sessions of anodal tDCS (2 mA, 20 min).
Receives: Other: transcranial direct current stimulation; Other: Physical exercise
Exercise + Sham tDCSSham comparatorIntervention will last 8 weeks where participants will be trained at a rate of 3 workouts per week. For the first week, participants will receive 5 daily sessions of sham tDCS.
Receives: Other: Physical exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Pain intensity

    Pain intensity will be assessed with a pain logbook containing a numerical rating scale from 0 to 10

    Measured: Before intervention (T1), First week of intervention (T2), Week 4 (T3), Week 8 (T4), Follow-up 1 week after intervention (T5), Follow-up 1 month after intervention (T6)

Secondary outcomes (11)
  1. Corticospinal excitability (TMS)

    Corticospinal tract excitability will be assessed with transcranial magnetic stimulation (TMS)

    Measured: Before intervention, Follow-up 1 week after, Follow-up 1 month after

  2. Corticospinal excitability (dMRI)

    Corticospinal tract excitability will be assessed diffusion magnetic resonance imaging

    Measured: Before intervention, Follow-up 1 week after, Follow-up 1 month after

  3. Functional connectivity

    Functional connectivity will be assessed with functional magnetic resonance imaging

    Measured: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  4. McGill pain questionnaire

    McGill pain questionnaire will be used to assess pain in its globality. Score from 0 to 72, higher score means worse outcome.

    Measured: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  5. Brief pain inventory

    Brief pain inventory will be used to assess pain in its globality. Score from 0 to 70, higher score means worse outcome

    Measured: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  6. Beck depression inventory

    Beck depression inventory will be used to assess pain in its globality. Score from 0 to 39, higher score means worse outcome

    Measured: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  7. Beck anxiety inventory

    Beck anxiety inventory will be used to assess pain in its globality. Score from 0 to 63, higher score means worse outcome

    Measured: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  8. Margolis pain drawing and scoring system

    Margolis pain drawing and scoring system will be used to assess pain in its globality. Score from 0 to 45, higher score means worse outcome

    Measured: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  9. Patient global impression of change questionnaire

    patient global impression of change questionnaire will be used to assess pain in its globality. Score from 0 to 18 and a percentage from 0 to 100. Higher scores mean better outcome

    Measured: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  10. Tampa questionnaire

    Tampa questionnaire will be used to assess pain in its globality. Score from 0 to 68, higher score means worse outcome

    Measured: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

  11. Pain catastrophizing scale

    Pain catastrophizing scale will be used to assess pain in its globality. Score from 0 to 52, higher score means worse outcome

    Measured: Before intervention, Follow-up 1 week after intervention, Follow-up 1 month after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2020
  2. Study start1 Dec 2020
  3. Primary completion1 Oct 2023 (estimated)
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04332939
Sponsor's protocol ID
2020-3273
Status last verified
Mar 2023
First submitted
23 Jan 2020
Last updated
27 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing transcranial direct current stimulation and Physical exercise in people with Chronic Pain, run by Université de Sherbrooke at 2 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Guillaume Léonard, PhD. pht (1 819-780-2220 ext. 45246, guillaume.leonard2@usherbrooke.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Pain intensity (time frame: Before intervention (T1), First week of intervention (T2), Week 4 (T3), Week 8 (T4), Follow-up 1 week after intervention (T5), Follow-up 1 month after intervention (T6)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04332939 | AzTrials